Popular searches: AAPL TSLA NVDA MSFT GOOGL

NBIX Stock Price Prediction 2026

Neurocrine Biosciences Inc

$128.32
$-4.10 (-3.1%)

AI-powered price predictions based on fundamental analysis and growth projections

Last Updated: March 27, 2026

NBIX Price Forecast 2026: Our AI models project that NBIX stock will fall to approximately $124.21 by 2026. This represents a potential 3.2% contraction from the current trading price of $128.32. The overall market sentiment for NBIX is currently neutral, based on a combination of proprietary technical signals and fundamental analysis.

Fundamental Analysis: Trading at a P/E ratio of 28.3, with its most recent quarterly earnings growing by 0.5%. NBIX shows a complex fundamental profile. Our model evaluates these metrics alongside sector peers and historical performance to derive the 2026 price target. If the company exceeds its current growth projections, there may be further upside beyond our base case scenario.

Technical Outlook: The stock is technically in a downtrend phase. The Relative Strength Index (RSI) is currently 45.0, which suggests the stock is trading in a neutral range. Traders should monitor key support and resistance levels closely, as a breakout or breakdown from current price consolidation will be the primary catalyst for the stock reaching the 2026 predicted target.

🎯
AI TRADING RECOMMENDATION
Evaluate position
Key Signals:
  • TTM Squeeze ON for 13 days - volatility compression
  • Price consolidating in 4.15% range for 17 days
  • Moving averages converging - equilibrium state
  • MACD bullish crossover - upward momentum
  • Price near support at $127.05
MACD: Bullish | Volume: Neutral
Fair Value Estimate
+11.0% Undervalued
Fair Value: $142.43 (Current: $128.32)

Based on PEG ratio analysis, this stock appears undervalued at current levels. The fair value estimate suggests 11.0% upside potential.

PEG Ratio
0.58
Attractive
Current P/E
22.47
Fair P/E
24.94
Earnings Growth
38.7%
📉

Volume Trend: Neutral

Selling Pressure Present - Distribution pattern observed

Chaikin Money Flow (CMF): -0.040
Money Flow Index (MFI): 43.5

Negative CMF indicates money flowing out of the stock. Exercise caution as this may signal distribution.

Options Analysis: 1-Year Target Strategy

Score: 47/100

Analysts project the stock to decline. Options analysis identifies premium selling opportunities (covered calls, credit spreads).

CONSIDER SELLING - Moderate premium selling opportunity. Target 3.6% below.
Growth Target (1Y)
$123.08
-3.6% (below current)
Best Strike Found
$135.00
Exp: Jan. 15, 2027, midnight
Call Premium
$17.25
13.5% of stock price
Breakeven Price
$152.25
⚠ Above target
Implied Probability
53.6%
Market's confidence
Value Score
-100.0
Overpriced
📉
STRONG SELL
Analysts expect stock to decline - Sell calls to collect premium
Seller's Advantage:
Premium Collected
$17.25
Profit if Target Hits
$17.25
ROI if Target Hits
+100.0%
Why This Works: Buyers lose 100.0% even if target hits. Premium is overpriced for -3.6% move.
Suggested Strategies: Covered Call (safest) Naked Call (risky) Credit Spread (defined risk)
Open Interest: 3 | Volume: 1
Data as of: Mar 20, 2026
How to Use This Analysis: Value Score shows profitability if the 1-year growth target is reached. Positive score = profitable for buyers. Negative score = profit opportunity for premium sellers (covered calls, credit spreads).
Price Targets by Timeframe
AI-based growth projections (not Wall Street analyst targets)
Timeframe Target Price Potential Return
30 Days $127.99 -0.3%
90 Days $127.29 -0.8%
6 Months $126.26 -1.6%
1 Year $124.21 -3.2%
2 Years EXTENDED $120.24 -6.3%
3 Years EXTENDED $116.39 -9.3%

More NBIX Analysis

Why is NBIX Moving? Buy or Sell NBIX? NBIX Full Analysis NBIX Trendline Analysis
NBIX Price Prediction Trendline

Scenario Analysis (1-Year Outlook)

Bull Case
30% Probability
$155.26 (+21.0%)

Best case scenario if strong fundamentals and market conditions align

Base Case
50% Probability
$124.21 (+-3.2%)

Expected scenario based on current growth trajectory

Bear Case
20% Probability
$86.95 (-32.2%)

Downside scenario if market headwinds or disappointing results

Technical Indicators

RSI (14)
45.0
Neutral
MACD Signal
Bullish
Trend
Downtrend
Money Flow (CMF)
-0.04

Key Fundamentals

P/E Ratio
28.29
Forward P/E
22.47
P/S Ratio (TTM)
4.65x
Fair
Revenue Growth (QoQ)
0.3%
Earnings Growth (QoQ)
0.5%
Market Cap
$13,290M
Analyst Target
$178.04
52-Week High
$132.42
52-Week Low
$128.32

Options Activity

Alert Score
85/100
Classification
Strong Alert
Unusual Activity
80.0
IV Spike
+78.7%

Recommendation: Strong unusual activity detected. Review for potential entry.

Frequently Asked Questions

What is the NBIX stock price prediction for 2026?

Based on our AI analysis, NBIX is predicted to reach $124.21 by 2026, representing a potential 3.2% decrease from the current price of $128.32.

Is NBIX stock a good buy right now?

Our analysis suggests NBIX is a "HOLD" based on current technical and fundamental indicators. With a projected 3.2% downside, investors should consider their risk tolerance and investment horizon.

What is NBIX 52-week high and low?

NBIX has a 52-week high of $132.42 and a 52-week low of $128.32. The stock is currently trading 3.1% below its 52-week high.

What is the technical analysis for NBIX?

NBIX is currently in a downtrend trend. The RSI of 45.0 indicates the stock is trading in neutral territory. Traders should monitor support and resistance levels for potential entry points.

Where will NBIX stock be in 3 years?

Our long-term projection estimates NBIX could reach $116.39 by 2028, representing a 9.3% decline from current levels. Long-term predictions carry more uncertainty.

Investment Disclaimer: These price predictions are generated using AI models and historical data. They are not financial advice and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Buy or Sell Analysis Trendline Analysis Investment Advisor Options Advisor Options Chain & Analysis